Cancer Screening
Digital breast tomosynthesis may reduce interval cancer rates vs. traditional screening
Digital breast tomosynthesis appeared associated with reductions in interval breast cancer rates compared with traditional digital mammography among a large cohort of women in Sweden, according to study results published in Radiology.
Stool-based colorectal cancer screening preferred over colonoscopy
Individuals preferred stool-based screening for colorectal cancer over colonoscopy, according to survey results published in Cancer Prevention Research.
‘Concerted effort’ needed to reduce cancer mortality by 4% annually, NCI director says
Reducing the cancer mortality rate by 4% per year through 2026 would cut the rate to half of its all-time peak, NCI Director Norman E. “Ned” Sharpless, MD, told attendees of the virtual American Association for Cancer Research Annual Meeting.
VIDEO: Role of breast cancer awareness in patient care
Healio spoke with Debu Tripathy, MD, about the importance of breast cancer awareness.
‘Harmful effect’ of pandemic emerges as clinics see patients with more advanced cancer
New patients arrived at cancer clinics with more advanced disease than prior to the COVID-19 pandemic as treatment postponements and deferrals subsided, according to results of a physician survey by American Society for Radiation Oncology.
Top in hem/onc: Biden’s tax proposals, updated lung cancer screening guidance
The top story in hematology/oncology last week was a comprehensive review of what President Joe Biden’s tax proposals could mean for physicians.
American Society of Preventive Oncology names president-elect
Anita Kinney, PhD, has been chosen president-elect of American Society of Preventive Oncology, which advocates for cancer prevention and control research.
Task force: Start lung cancer screening at age 50 years, 20 pack-years of smoking
The U.S. Preventive Services Task Force issued its final guidance on lung cancer screening, lowering the age to start screening to 50 years and the required smoking history to 20 pack-years.
‘Sequelae of COVID-19 pandemic’: Delays in breast cancer diagnoses, treatment
Erica T. Warner, ScD, MPH, spoke with Healio about the delays in diagnosis and treatment of breast cancer caused by COVID-19, whether the health care system is now better equipped to deal with the changes in screening, diagnosis and treatment resulting from COVID-19 and if introduction of the vaccine will affect care for patients with breast cancer.
Regularly attending screening mammography reduces breast cancer mortality risk
Undergoing mammography for 2 consecutive years before a breast cancer diagnosis conferred a significant reduction in mortality compared with skipping one or both screenings, according to prospective study results published in Radiology.